Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06444386 · ClinicalTrials.gov registry record
ECGi of SyncAV With MultiPoint Pacing
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 30
- Enrollment target
NCT06444386 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 30 participants.
The verdict
NCT06444386 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The objective of this clinical study was to evaluate the impact of Multipoint Pacing (MPP) and SyncAV programming on ventricular electrical activation time and activation sequence using noninvasive electrocardiographic imaging (ECGi) in patients receiving cardiac resynchronization therapy (CRT).
Interventions
- DEVICE MPP + SyncAV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2024-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06444386
The ClinicalTrials.gov registry entry for NCT06444386 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MPP + SyncAV is the first listed.
NCT06444386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06444386 about?
NCT06444386 is a clinical study titled "ECGi of SyncAV With MultiPoint Pacing". The objective of this clinical study was to evaluate the impact of Multipoint Pacing (MPP) and SyncAV programming on ventricular electrical activation time and activation sequence using noninvasive electrocardiographic imaging (ECGi) in patients receiving cardiac resynchronization therapy (CRT).
What is the current status of trial NCT06444386?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-09-29. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT06444386?
The interventions under investigation include: MPP + SyncAV (DEVICE).
Who is sponsoring clinical trial NCT06444386?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.